Drs. Karl and Spencer discuss the concept of "microdosing" GLP-1 receptor agonists along with talk about the new top line results from REDEFINE which studied the new drug CagriSema.
Hosts & Guests
Information
- Show
- FrequencyUpdated weekly
- Published23 December 2024 at 20:38 UTC
- Length40 min
- Episode106
- RatingExplicit